Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SYNGENE INTERNATIONAL LTD.

NSE : SYNGENEBSE : 539268ISIN CODE : INE398R01022Industry : Business SupportHouse : Private

BSE680.7511.35 (+1.7 %)

PREV CLOSE ( ) 669.40

OPEN PRICE ( ) 670.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 53224

TODAY'S LOW / HIGH ( )667.15 693.45

52 WK LOW / HIGH ( )598.55 960

NSE681.1011.35 (+1.69 %)

PREV CLOSE( ) 669.75

OPEN PRICE ( ) 667.40

BID PRICE (QTY) 681.10 (4)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3025346

TODAY'S LOW / HIGH( ) 665.70 693.00

52 WK LOW / HIGH ( )599.55 960.6

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1993

Management Info

Kiran Mazumdar-Shaw - Chairman Peter Bains - Managing Director

Registered Office

Address Biocon Sez, Biocon Park, No 2 & 3, Bommasandra,Industrail Area, Iv Pahse,Jigani Link Rd,
Bengaluru,
Karnataka-560099

Phone 080 6891 8000 / 9191

Email investor@syngeneintl.com

Website www.syngeneintl.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

19Jul Syngene International informs about c
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

14Jun USFDA conducts GCP compliance inspecti
United States Food and Drug Administration (USFDA) has conducted a Good..

14Jun Syngene International informs about re
Syngene International has informed about Receipt of Establishment Inspec..

22Apr Syngene International informs about di
Further to its previous intimation having reference no. Syn/CS/SE/Reg 30..

11Mar Syngene International’s arm acquires f
Syngene International’s wholly-owned subsidiary -- Syngene USA Inc. has..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	740	4680
Gross Profit	842	6216
Operating Profit	1847	9881
Net Sales	7993	33733

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Vimta Labs (BSE) 584.75 (15.62%)	M.Cap ( in Cr)2602.46
EFC (I) (BSE) 350.25 (0.50%)	M.Cap ( in Cr)3486.86
EKI Energy Services (BSE) 129.80 (0.89%)	M.Cap ( in Cr)358.30
Icon Facilitators (BSE) 51.27 (0.53%)	M.Cap ( in Cr)40.30
AGS Transact Tech (BSE) 5.21 (1.96%)	M.Cap ( in Cr)66.91

Shareholding Pattern

	PROMOTERS	52.68%
	MUTUAL FUNDS/UTI	20.7%
	NON-INSTITUTION	6.77%
	FI/BANKS/INSURANCE	3.16%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
LIC MF Healthcare F...	2.87
Mirae Asset Focused...	2.73
Bajaj Finserv Healt...	2.53
DSP Focused Fund-Reg(G)	2.40
ICICI Pru Pharma He...	2.39
DSP Multicap Fund-Reg(G)	2.39
Nippon India Innova...	2.33

Risk Disclosures on Derivatives

Smart Quotes

SYNGENE INTERNATIONAL LTD.